ArticleJournal of clinical medicine2022

Comparative Safety of Ustekinumab and Vedolizumab in Older Patients with Inflammatory Bowel Disease: A Bicentric Cohort Study.

Alice Burgevin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.